Universal Health Services (UHS) Projected to Post Quarterly Earnings on Wednesday

Universal Health Services (NYSE:UHS) is projected to announce its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of $4.21 per share and revenue of $4.01 billion for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Universal Health Services Price Performance

NYSE UHS opened at $179.93 on Monday. Universal Health Services has a 12 month low of $152.68 and a 12 month high of $243.25. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.39 and a quick ratio of 1.28. The firm has a market capitalization of $11.87 billion, a PE ratio of 11.96, a P/E/G ratio of 0.53 and a beta of 1.30. The company’s 50 day simple moving average is $184.27 and its 200 day simple moving average is $206.09.

Universal Health Services Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be paid a dividend of $0.20 per share. The ex-dividend date is Monday, March 3rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.44%. Universal Health Services’s dividend payout ratio is presently 5.32%.

Analysts Set New Price Targets

A number of research analysts recently commented on UHS shares. StockNews.com lowered shares of Universal Health Services from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 9th. Bank of America initiated coverage on shares of Universal Health Services in a research report on Wednesday, November 6th. They issued a “neutral” rating and a $223.00 price target on the stock. Royal Bank of Canada decreased their price target on shares of Universal Health Services from $222.00 to $211.00 and set a “sector perform” rating on the stock in a research report on Monday, October 28th. The Goldman Sachs Group lowered shares of Universal Health Services from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $228.00 to $198.00 in a research report on Monday, December 16th. Finally, Wells Fargo & Company decreased their price target on shares of Universal Health Services from $285.00 to $230.00 and set an “overweight” rating on the stock in a research report on Monday, November 25th. Six equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $226.14.

Insider Buying and Selling

In related news, Director Maria Ruderman Singer sold 1,614 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $191.15, for a total value of $308,516.10. Following the completion of the transaction, the director now owns 5,879 shares of the company’s stock, valued at approximately $1,123,770.85. This trade represents a 21.54 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 16.10% of the company’s stock.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.